RAF1 and lung carcinoma: Our data also build on a recent report by Rai and co-workers in which delivery of miR-7 to EGFR inhibitor-resistant lung cancer cells suppressed growth in vitro and in vivo, an effect that was associated with decreased expression of EGFR as well as its downstream kinases RAF1 and IRS1 [31].